Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/33266
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorOLIVEIRA-FILHO, Aldemir B.
dc.contributor.authorSANTOS, Francisco Junior A.
dc.contributor.authorSILVA, Fabricio Quaresma
dc.contributor.authorRAIOL, Nairis Costa
dc.contributor.authorCOSTA, Camila Carla S.
dc.contributor.authorPIAUIENSE, Juliana Nadia F.
dc.contributor.authorMARTINS, Luisa Caricio
dc.contributor.authorCARDOSO, Yasmin Maria N.
dc.contributor.authorMICELI, Jeruza Ferraz F. Di
dc.contributor.authorRESQUE, Rafael Lima
dc.contributor.authorSILVA-OLIVEIRA, Glaucia C.
dc.contributor.authorPINHEIRO, Luiz Marcelo L.
dc.contributor.authorMACHADO, Luiz Fernando A.
dc.contributor.authorPINHO, Joao Renato R.
dc.contributor.authorLEMOS, Jose Alexandre R.
dc.contributor.authorKUPEK, Emil
dc.contributor.authorFISCHER, Benedikt
dc.date.accessioned2019-08-20T14:53:20Z-
dc.date.available2019-08-20T14:53:20Z-
dc.date.issued2019
dc.identifier.citationBMC INFECTIOUS DISEASES, v.19, article ID 634, 10p, 2019
dc.identifier.issn1471-2334
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/33266-
dc.description.abstractBackgroundElevated rates of Hepatitis C Virus (HCV) infection have been reported in epidemiological studies with people who used illicit drugs (PWUIDs) in different Brazilian regions. In Brazil's Amazon region, studies have already identified the common use of illicit drugs among adolescents and the high prevalence of HCV infections among PWUIDs. However, all studies done with PWUIDs were conducted with small samples and within limited geographic coverage. This study determined the prevalence and risk factors for HCV infection in PWUIDs in the Amazon region, northern Brazil, as well as estimating the prevalence and factors associated with the HCV spontaneous clearance (HSC).MethodsThis cross-sectional study accessed 1666 PWUIDs from multiple municipalities of the Amazon region. Socio-demographic, economic, drug use and health-related information were collected through interviews. Blood samples collected were tested for the presence of anti-HCV antibodies and RNA-HCV. HCV genotypes were identified by real-time polymerase chain reaction (PCR). Logistic regressions were run to identify factors independently associated with HCV infection status and HSC.ResultsIn total, 577 (34.6%) featured HCV antibodies, of which 384 (23.1%) had active HCV infection and 193 (11.6%) indicated HSC. Genotypes 1 (80.2%) and 3 (18.8%) were detected. HCV infection status was associated with the length of illicit drug use history, factors related to parenteral and sexual transmission, and factors of socio-economic marginalization leading to potential risk activities for HCV. HSC was associated with the ethnic (including indigenous) background of participants.ConclusionsHigh levels of HCV infection were detected in PWUIDs. Genotype 1 was predominant. Intense use of illicit drugs, unprotected sexual intercourse, high number of sexual partners and social marginalization were associated with all HCV infection. HSC was associated with origin (Amazonian-born) and non-white (e.g., Black or Indigenous) of PWUIDs. These findings emphasize the need for improve HCV prevention and control services and care for PWUIDs in the Brazilian Amazon region.eng
dc.description.sponsorshipMinisterio da Saude/Secretaria de Vigilancia em Saude (MS/SVS)
dc.description.sponsorshipConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)
dc.description.sponsorshipCNPQ fellowships
dc.description.sponsorshipCoordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) fellowships
dc.language.isoeng
dc.publisherBMCeng
dc.relation.ispartofBMC Infectious Diseases
dc.rightsopenAccesseng
dc.subjectHCVeng
dc.subjectEpidemiologyeng
dc.subjectSpontaneous clearanceeng
dc.subjectPeople who used illicit drugseng
dc.subjectBrazileng
dc.subjectAmazoneng
dc.subject.otherhcv infectioneng
dc.subject.otherglobal epidemiologyeng
dc.subject.otherinject drugseng
dc.subject.othercocaine userseng
dc.subject.otherprevalenceeng
dc.subject.othertransmissioneng
dc.subject.othergenotypeseng
dc.subject.othercrackeng
dc.subject.otherriskeng
dc.subject.otherhiveng
dc.titleHepatitis C virus infection status and associated factors among a multi-site sample of people who used illicit drugs in the Amazon regioneng
dc.typearticleeng
dc.rights.holderCopyright BMCeng
dc.identifier.doi10.1186/s12879-019-4270-2
dc.identifier.pmid31315569
dc.subject.wosInfectious Diseaseseng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
hcfmusp.author.externalOLIVEIRA-FILHO, Aldemir B.:Univ Fed Para, Lab Celulas & Patogenos, Grp Estudo & Pesquisa Populacoes Vulneraveis GEPP, Inst Estudos Costeiros, Campus Braganca,Alameda Leandro Ribeiro S-N, Braganca, PA, Brazil
hcfmusp.author.externalSANTOS, Francisco Junior A.:Univ Fed Para, Lab Celulas & Patogenos, Grp Estudo & Pesquisa Populacoes Vulneraveis GEPP, Inst Estudos Costeiros, Campus Braganca,Alameda Leandro Ribeiro S-N, Braganca, PA, Brazil
hcfmusp.author.externalSILVA, Fabricio Quaresma:Univ Fed Para, Lab Celulas & Patogenos, Grp Estudo & Pesquisa Populacoes Vulneraveis GEPP, Inst Estudos Costeiros, Campus Braganca,Alameda Leandro Ribeiro S-N, Braganca, PA, Brazil
hcfmusp.author.externalRAIOL, Nairis Costa:Univ Fed Para, Lab Celulas & Patogenos, Grp Estudo & Pesquisa Populacoes Vulneraveis GEPP, Inst Estudos Costeiros, Campus Braganca,Alameda Leandro Ribeiro S-N, Braganca, PA, Brazil
hcfmusp.author.externalCOSTA, Camila Carla S.:Univ Fed Para, Lab Celulas & Patogenos, Grp Estudo & Pesquisa Populacoes Vulneraveis GEPP, Inst Estudos Costeiros, Campus Braganca,Alameda Leandro Ribeiro S-N, Braganca, PA, Brazil; Univ Fed Para, Lab Patol Clin Doencas Tropicais, Nucleo Med Trop, Belem, Para, Brazil
hcfmusp.author.externalPIAUIENSE, Juliana Nadia F.:Univ Fed Para, Lab Celulas & Patogenos, Grp Estudo & Pesquisa Populacoes Vulneraveis GEPP, Inst Estudos Costeiros, Campus Braganca,Alameda Leandro Ribeiro S-N, Braganca, PA, Brazil; Univ Fed Para, Lab Patol Clin Doencas Tropicais, Nucleo Med Trop, Belem, Para, Brazil
hcfmusp.author.externalMARTINS, Luisa Caricio:Univ Fed Para, Lab Patol Clin Doencas Tropicais, Nucleo Med Trop, Belem, Para, Brazil
hcfmusp.author.externalCARDOSO, Yasmin Maria N.:Univ Fed Amapa, Lab Toxicol & Quim Farmaceut, Ctr Ciencias Biol & Saude, Macapa, AP, Brazil
hcfmusp.author.externalMICELI, Jeruza Ferraz F. Di:Univ Fed Amapa, Lab Toxicol & Quim Farmaceut, Ctr Ciencias Biol & Saude, Macapa, AP, Brazil
hcfmusp.author.externalRESQUE, Rafael Lima:Univ Fed Amapa, Lab Toxicol & Quim Farmaceut, Ctr Ciencias Biol & Saude, Macapa, AP, Brazil
hcfmusp.author.externalSILVA-OLIVEIRA, Glaucia C.:Univ Fed Para, Lab Celulas & Patogenos, Grp Estudo & Pesquisa Populacoes Vulneraveis GEPP, Inst Estudos Costeiros, Campus Braganca,Alameda Leandro Ribeiro S-N, Braganca, PA, Brazil
hcfmusp.author.externalPINHEIRO, Luiz Marcelo L.:Univ Fed Para, Fac Ciencias Biol, Campus Marajo Soure, Soure, PA, Brazil
hcfmusp.author.externalMACHADO, Luiz Fernando A.:Univ Fed Para, Lab Virol, Inst Ciencias Biol, Belem, PA, Brazil
hcfmusp.author.externalLEMOS, Jose Alexandre R.:Univ Fed Para, Programa Posgrad Profiss Anal Clin, Inst Ciencias Biol, Belem, PA, Brazil
hcfmusp.author.externalKUPEK, Emil:Univ Fed Santa Catarina, Dept Saude Publ, Florianopolis, SC, Brazil
hcfmusp.author.externalFISCHER, Benedikt:CAMH, Inst Mental Hlth Policy Res, Toronto, ON, Canada; Univ Toronto, Dept Psychiat, Toronto, ON, Canada; Univ Auckland, Fac Med & Hlth Sci, Grafton, AK, New Zealand
hcfmusp.description.articlenumber634
hcfmusp.description.volume19
hcfmusp.origemWOS
hcfmusp.origem.idWOS:000475922100006
hcfmusp.origem.id2-s2.0-85069456855
hcfmusp.publisher.cityLONDONeng
hcfmusp.publisher.countryENGLANDeng
hcfmusp.relation.referenceAaron S, 2008, CLIN INFECT DIS, V47, P931, DOI 10.1086/591699eng
hcfmusp.relation.referenceAbdalla RR, 2014, ADDICT BEHAV, V39, P297, DOI 10.1016/j.addbeh.2013.10.019eng
hcfmusp.relation.referenceAceijas C, 2007, INT J DRUG POLICY, V18, P352, DOI 10.1016/j.drugpo.2007.04.004eng
hcfmusp.relation.referenceAisyah DN, 2018, J VIRAL HEPATITIS, V25, P680, DOI 10.1111/jvh.12866eng
hcfmusp.relation.referenceAndrade AP, 2017, ARCH VIROL, V162, P227, DOI 10.1007/s00705-016-3060-zeng
hcfmusp.relation.reference[Anonymous], 2012, WORLD DRUG REP 2012eng
hcfmusp.relation.referenceAraujo AR, 2011, REV SOC BRAS MED TRO, V44, P638, DOI 10.1590/S0037-86822011000500024eng
hcfmusp.relation.referenceAsselah T, 2016, LIVER INT, V36, P47, DOI 10.1111/liv.13027eng
hcfmusp.relation.referencePacheco SDB, 2014, REV SOC BRAS MED TRO, V47, P367, DOI 10.1590/0037-8682-0153-2013eng
hcfmusp.relation.referenceButler AJ, 2017, DRUG ALCOHOL DEPEN, V180, P401, DOI 10.1016/j.drugalcdep.2017.08.036eng
hcfmusp.relation.referenceCallegari-Jacques SM, 2003, AM J HUM BIOL, V15, P824, DOI 10.1002/ajhb.10217eng
hcfmusp.relation.referenceCruz MS, 2013, INT J DRUG POLICY, V24, P432, DOI 10.1016/j.drugpo.2013.03.012eng
hcfmusp.relation.referenceCunningham EB, 2015, NAT REV GASTRO HEPAT, V12, P218, DOI 10.1038/nrgastro.2015.36eng
hcfmusp.relation.referencede Paula VS, 2001, MEM I OSWALDO CRUZ, V96, P1123, DOI 10.1590/S0074-02762001000800016eng
hcfmusp.relation.referencede Sa LC, 2013, REV LAT-AM ENFERM, V21, P1195, DOI 10.1590/0104-1169.3126.2354eng
hcfmusp.relation.referenceDegenhardt L, 2012, LANCET, V379, P55, DOI 10.1016/S0140-6736(11)61138-0eng
hcfmusp.relation.referenceDuailibi LB, 2008, CAD SAUDE PUBLICA, V24, P545, DOI 10.1590/S0102-311X2008001600007eng
hcfmusp.relation.referenceFerrari J O, 1999, Rev Soc Bras Med Trop, V32, P299eng
hcfmusp.relation.referenceFischer B, 2008, EUR J GASTROEN HEPAT, V20, P29, DOI 10.1097/MEG.0b013e3282f16a8ceng
hcfmusp.relation.referenceFischer B, 2013, INT J DRUG POLICY, V24, P631, DOI 10.1016/j.drugpo.2013.09.003eng
hcfmusp.relation.referenceFurtado IM, 2017, J DRUG ABUSE, V3, P1, DOI 10.21767/2471-853x.100041eng
hcfmusp.relation.referenceGrebely J, 2007, CAN J GASTROENTEROL, V21, P447, DOI 10.1155/2007/796325eng
hcfmusp.relation.referenceHershow RC, 1998, SEX TRANSM DIS, V25, P527, DOI 10.1097/00007435-199811000-00006eng
hcfmusp.relation.referenceLanini S, 2016, CLIN MICROBIOL INFEC, V22, P833, DOI 10.1016/j.cmi.2016.07.035eng
hcfmusp.relation.referenceLayden JE, 2015, CLIN INFECT DIS, V60, P1033, DOI 10.1093/cid/ciu965eng
hcfmusp.relation.referenceLopes Carmen L R, 2009, Rev. Saúde Pública, V43, P43, DOI 10.1590/S0034-89102009000800008eng
hcfmusp.relation.referenceMarx MA, 2003, CLIN INFECT DIS, V37, P514, DOI 10.1086/376639eng
hcfmusp.relation.referenceMathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2eng
hcfmusp.relation.referenceNelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0eng
hcfmusp.relation.referenceNunes CLX, 2007, BRAZ J INFECT DIS, V11, P561, DOI 10.1590/S1413-86702007000600007eng
hcfmusp.relation.referenceOliveira MLA, 2009, EPIDEMIOL INFECT, V137, P970, DOI 10.1017/S0950268808001970eng
hcfmusp.relation.referenceOliveira AB, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-38eng
hcfmusp.relation.referenceOliveira AB, 2013, ARCH VIROL, V158, P1555, DOI 10.1007/s00705-013-1627-5eng
hcfmusp.relation.referenceOliveira AB, 2010, MEM I OSWALDO CRUZ, V105, P103, DOI 10.1590/S0074-02762010000100016eng
hcfmusp.relation.referencePereira LMMB, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-60eng
hcfmusp.relation.referencePrati D, 2006, J HEPATOL, V45, P607, DOI 10.1016/j.jhep.2006.07.003eng
hcfmusp.relation.referencePybus Oliver G, 2005, Infect Genet Evol, V5, P131eng
hcfmusp.relation.referenceReis GKM, 2017, 5 CONVIBRA GESTAO EDeng
hcfmusp.relation.referenceRobaeys G, 2016, J HEPATOL, V65, P1094, DOI 10.1016/j.jhep.2016.07.042eng
hcfmusp.relation.referencede Freitas MDR, 2013, J MED VIROL, V85, P1741, DOI 10.1002/jmv.23654eng
hcfmusp.relation.referenceSantos FJA, 2017, DRUG ADDICTIONeng
hcfmusp.relation.referenceSawada L, 2011, REV SOC BRAS MED TRO, V44eng
hcfmusp.relation.referenceScheinmann R, 2007, DRUG ALCOHOL DEPEN, V89, P1, DOI 10.1016/j.drugalcdep.2006.11.014eng
hcfmusp.relation.referenceSilva FQ, 2018, ARCH VIROL, V163, P617, DOI 10.1007/s00705-017-3656-yeng
hcfmusp.relation.referenceSilva MBS, 2010, MEM I OSWALDO CRUZ, V105, P299, DOI 10.1590/S0074-02762010000300009eng
hcfmusp.relation.referenceSousa RAC, 2017, TROPICAL MEDeng
hcfmusp.relation.referenceTe Helen S, 2010, Clin Liver Dis, V14, P1, DOI 10.1016/j.cld.2009.11.009eng
hcfmusp.relation.referenceThursz M, 2014, NAT REV GASTRO HEPAT, V11, P28, DOI 10.1038/nrgastro.2013.179eng
hcfmusp.relation.referenceUrbanus AT, 2009, AIDS, V23, pF1, DOI 10.1097/QAD.0b013e32832e5631eng
hcfmusp.relation.referenceValois RC, 2014, REV INST MED TROP SP, V56, P511, DOI 10.1590/S0036-46652014000600010eng
hcfmusp.relation.referenceWestbrook RH, 2014, J HEPATOL, V61, pS58, DOI 10.1016/j.jhep.2014.07.012eng
dc.description.indexMEDLINEeng
hcfmusp.citation.scopus14-
hcfmusp.scopus.lastupdate2024-03-29-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - IMT
Instituto de Medicina Tropical - IMT

Artigos e Materiais de Revistas Científicas - LIM/03
LIM/03 - Laboratório de Medicina Laboratorial

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar


Files in This Item:
File Description SizeFormat 
art_OLIVEIRA-FILHO_Hepatitis_C_virus_infection_status_and_associated_factors_2019.PDFpublishedVersion (English)853.08 kBAdobe PDFThumbnail
View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.